Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Souilah, F. Z. El Allia, M. Kacimi, A. Fissah, S. Taright, R. Amrane (Algiers, Algeria). Prognostic factors for survival in lung cancer. Eur Respir J 2013; 42: Suppl. 57, 2922

Member's Comments

No comment yet.

Related content which might interest you: Survival in lung cancer: Associated factors in Tunisian patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 The prognostic value of D-dimer in lung carcinoma Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Algorithm of preoperative N-staging of non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis? Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Locally advanced stage nonsmallcell cancers explode in hyperglisemia: A new prognostic factors? Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 EBUS-TBNA for nodal restaging and relapse in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Comorbitities, responses and survival in pts with NSCLC Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Prognostic value of preoperative C-reactive protein in resectable non-small cell lung cancer - 5-years prospective study Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 The prognostic value of the tumor shrinkage rate for progression-free survival in patients with non-small cell lung cancer receiving gefitinib Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Clinico-pathological prognostic factors for relapse in early stage non-small cell lung cancer after radical surgical resection Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Prognostic value of EGFR mutation in NSCLC in surgical stage Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Reduced perioperative mortality after centralization of lung cancer surgery Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013